Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.
about
Pancreatic cancer and thromboembolic disease, 150 years after TrousseauEvidence-based case report: multiple thrombotic episodes associated with lenalidomide and dexamethasone therapy for multiple myelomaWhat is the Best Treatment for a Cancer Patient with Thrombosis?Pharmacotherapy with oral Xa inhibitors for venous thromboembolism.Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a Danish population-based cohort studyDischarge or admit? Emergency department management of incidental pulmonary embolism in patients with cancer: a retrospective study.Treatment options for venous thromboembolism: lessons learnt from clinical trials.Determinants of venous thromboembolism among hospitalizations of US adults: a multilevel analysisEpidemiology, clinical profile and treatment patterns of venous thromboembolism in cancer patients in Taiwan: a population-based study.Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumorsReporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis.Rivaroxaban for the treatment of pulmonary embolism.A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis.Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia.Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients.Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads.Thrombosis in pediatric cancer: identifying the risk factors to improve care.Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995-2011.Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab.Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.Characterization of the antithrombotic fingerprint of the branded and copies of the low-molecular-weight enoxaparin using thrombin generation assay.Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy.Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer.Neoadjuvant chemoradiation for rectal cancer is not associated with higher rates of thromboembolism.Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers.Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).Thromboprophylaxis among Australasian colorectal surgeons.Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma.Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.The incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma.
P2860
Q26775634-F7A6D477-ED16-41F0-8AB6-355BD9326FC0Q26823292-380DE8F5-9161-4ADD-9094-3B240A6D5B98Q27009514-ABEDCF55-F13D-407B-ADF8-21A9C0CC8EE9Q33419567-1E61B017-3B97-4A92-A90E-9488829352D3Q33744868-81F96C1B-B95A-4CD4-BD5F-84F64231E5ACQ33769999-DE872570-6830-49A4-B9DB-69CC4BEEC19AQ34694544-EAF76719-C8EA-400F-BA8B-080A8BF615ABQ35447619-47360428-6145-44DF-B7D8-94D1C03FF997Q35552333-8A9918BF-3A3F-4C1A-A914-02C729CF1CAEQ35813082-D5286D6F-0806-4D32-A094-20965C6FCEB9Q36080543-41FE88E9-B2F4-4D5B-9D7F-A7D20020488AQ36997736-741FF3F7-F4EA-40F3-97F4-6625C7A26203Q37091111-3ACD61A6-3DF9-4D0A-BA53-4E54301CE9EDQ37404403-1E80DDFA-36D3-417C-9774-906C514B58E3Q37577927-1A7ABD44-91DD-4F1B-B1C8-BB58677BE1B6Q37669093-E76BCF30-D435-4B47-B02F-AA01E3BEE3CCQ38041947-79C2EDB8-B4B4-4B82-9C37-6417587F731AQ38152512-F165576B-A149-4555-886F-751131A9DBA1Q38413783-299B93D5-F3E0-4C7F-8E3B-5D60CA4BA1B0Q38674859-82773918-A69B-4114-B551-58CD631E945FQ38716326-C7320464-002C-4C5F-BC27-0914A4A48AC0Q38869704-24C4752E-89FA-44DD-A035-02B2323B264FQ41189502-8EF40A03-80EB-4DB2-84A2-6A808B94D8F7Q41554886-AC5B91C0-FBED-4B0E-8F0C-2F8D6EBC1F03Q41729508-BBE2287D-A6D4-4C4B-9B0F-35B5E0AB446AQ42126706-0A9EAD43-1437-4F2A-AC8B-A4269B3419BEQ46085597-FBE3E74C-01B9-488A-A746-EA8BE315A542Q46182709-BAA59B59-88FC-4445-8629-C2783F49715BQ52313102-623F7FF2-D3D1-48C3-A045-F93E9FD415B2Q52805260-2BA12602-1F90-45A4-99B0-241CDA2A8811Q55411209-22E2BDC7-4E5C-4225-9F8F-D81D4518CC93
P2860
Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Venous thromboembolism in the ...... enefits of thromboprophylaxis.
@en
Venous thromboembolism in the ...... enefits of thromboprophylaxis.
@nl
type
label
Venous thromboembolism in the ...... enefits of thromboprophylaxis.
@en
Venous thromboembolism in the ...... enefits of thromboprophylaxis.
@nl
prefLabel
Venous thromboembolism in the ...... enefits of thromboprophylaxis.
@en
Venous thromboembolism in the ...... enefits of thromboprophylaxis.
@nl
P2860
P356
P1433
P1476
Venous thromboembolism in the ...... enefits of thromboprophylaxis.
@en
P2093
Gary H Lyman
P2860
P304
P356
10.1002/CNCR.25714
P407
P577
2010-11-08T00:00:00Z